SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001104659-24-008866
Filing Date
2024-01-31
Accepted
2024-01-31 16:58:44
Documents
3

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm244278d1_sc13da.htm SC 13D/A 70987
2 EXHIBIT 99.1 tm244278d1_ex99-1.htm EX-99.1 220860
3 EXHIBIT 99.2 tm244278d1_ex99-2.htm EX-99.2 176933
  Complete submission text file 0001104659-24-008866.txt   470486
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filed by) CIK: 0000882095 (see all company filings)

IRS No.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Subject) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90423 | Film No.: 24583755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)